Clinical trial
Mitochondrial-Targeted Antioxidant Supplementation for Improving Cerebrovascular Function in Postmenopausal Women
NCT07406243 is registered in ClinicalTrials.gov with Colorado State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mitochondrial-Targeted Antioxidant Supplementation for Improving Cerebrovascular Function in Postmenopausal Women
- Lead sponsor
- Colorado State University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 30, 2026
- Completion date
- July 31, 2030
- Enrollment
- 86 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aging, postmenopause